GlassScriptPhysician profile
Stacy H Schroder
NPI 1295259034
$1,711.76
in general payments reported to CMS, 2019-2025
16 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $260 · 2022: $387 · 2023: $399 · 2024: $376 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777 · Education: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.87 |
| Education | $287.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $521.32 | 2021-2025 | Tremfya |
| Abbvie INC. | $297.76 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $255.84 | 2023-2024 | Sotyktu |
| Galderma Laboratories, L.P. | $164.01 | 2021-2025 | Nemluvio |
| Janssen Scientific Affairs, LLC | $101.06 | 2022 | |
| Incyte Corporation | $98.76 | 2021-2024 | Opzelura |
| Sun Pharmaceutical Industries INC. | $43.61 | 2023-2024 | Odomzo, Blu-U |
| Arcutis Biotherapeutics, INC. | $42.60 | 2025 | Zoryve |
| Amgen INC. | $40.62 | 2021 | |
| Genentech USA, INC. | $33.57 | 2024 | Erivedge |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $29.44 | 2021 | |
| Lilly USA, LLC | $23.21 | 2023 | Taltz, Olumiant |
| Novartis Pharmaceuticals Corporation | $16.72 | 2021 | |
| Leo Pharma INC. | $15.47 | 2024 | Adbry |
| Genentech, INC. | $14.60 | 2023 | Erivedge |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $13.17 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Schroder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.